Embodiments of the invention relate generally to the field of lithography processes for semiconductor manufacturing, and more specifically to photoresists for non-chemically amplified photoresist technologies constituted to reduce line wide roughness (LWR).
The manufacture of semiconductor devices typically includes a lithography process. Lithography typically involves various combinations of material deposition, etching, and chemical treatment. A portion of a typical lithography process would proceed as follows. A film (e.g., a metal film) layer is deposited on a substrate. The film layer is typically only a few nanometers (nm) thick. A photoresist layer is then spin-coated on the substrate (i.e., over the film layer). A photoresist (i.e., a positive photoresist) is a photosensitive material that becomes more soluble in aqueous base solvent (developer) upon exposure to light. The photo resist may typically be spun on to the substrate and may include solvents to ensure a uniform coating. Such photoresists may be soft baked after deposition to drive off excess solvents. The photoresist is then selectively exposed to light in specific places. Typically a mask (i.e., a transparent plate having a printed pattern) and a light source (scanner) are used to illuminate the specified portions of the photoresist layer. Then the exposed portion of the photoresist layer (e.g. the portion rendered more soluble in the developer through exposure) is etched. Subsequently the non-exposed portion of the photoresist layer is etched leaving the patterned film layer.
Over the past decade, as the trend toward smaller feature sizes continued, chemically-amplified photoresist technologies have become more prevalent. For example, I-line, with a photoresist wavelength (λ) of 365 nm employed a non-chemically-amplified photoresist. The typical near-UV positive photoresist consists of a polymer (resin) such as novolac and a photoactive dissolution inhibitor (e.g., diazonaphthoquinone (DNQ)). As photoresist technology moved toward deep ultra-violet (DUV) (λ=248 nm, 193 nm) the typical novolac/DNQ photoresist was found to be inadequate. This was due to the inability of such photoresists to become more transparent during exposure (unbleachability) in the DUV region. Chemically-amplified photoresists were developed to address this limitation.
For chemically amplified photoresists, the mechanism is different. Instead of PAC, Photoacid generator (PAG) is used. The resin (PHOST) in the photoresists are not soluble in developer. Upon exposure to the hv light, the dissolution rate increases substantially. This is due to the acid resulting from exposure of the PAG. The generated acid will deblock the PHOST to form PHS which is soluble in developer. The disadvantage of this approach is that during the post-exposure bake process, the acid produced by the exposure of the photoacid generator (PAG) will diffuse into the film. The diffusion is non-uniform and produces a situation where the polymer lacks sufficient randomness to deblock, which exacerbates the LWR problem for all wavelengths.
In prior art lithography processes, it is not possible to reduce LWR to approximately 1.5 nm, which would be acceptable for 15-16 nm feature sizes.
The invention may be best understood by referring to the following description and accompanying drawings that are used to illustrate embodiments of the invention. In the drawings:
Embodiments of the invention provide a non-chemically amplified photoresist that results in reduced LWR.
In the following description, numerous specific details are set forth. However, it is understood that embodiments of the invention may be practiced without these specific details. In other instances, well-known circuits, structures and techniques have not been shown in detail in order not to obscure the understanding of this description.
Reference throughout the specification to “one embodiment” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the present invention. Thus, the appearance of the phrases “in one embodiment” or “in an embodiment” in various places throughout the specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
Moreover, inventive aspects lie in less than all features of a single disclosed embodiment. Thus, the claims following the Detailed Description are hereby expressly incorporated into this Detailed Description, with each claim standing on its own as a separate embodiment of this invention.
In accordance with one embodiment of the invention provide a photoresist that employs a developer-soluble resin and a photoactive compound (PAC).
In various alternative embodiments the DSR may be made by vinyl acid, vinyl phenol, and vinyl phenol substitutes, among others, through free radical polymerization.
Process
At operation 610 a photoresist layer is deposited upon the film layer. In accordance with one embodiment of the invention, the photoresist includes a DSR and PAC. For one embodiment the DSR may be a polyhydroxystyrene-based (PHS-based) compound as illustrated in
The photoresist may be spun onto the substrate to ensure a uniform coating and to evenly distribute the PAC within the photoresist. The PAC reduces the DSR solubility in the developer through hydrogen bonding.
At operation 615 the photoresist is masked and exposed to a light source. For one embodiment the wavelength of the light source is in the extreme infrared (EUV) region. During exposure the incident light decomposes the PAC. The PAC will convert to carbonyl acid that promotes the solubility of the DSR in the developer. The unexposed portions of the photoresist, which contains PAC inhibits the dissolution of the photoresist in these areas.
At operation 620 the exposed portions of the photoresist layer are developed and etched using a conventional etching technique. In accordance with one embodiment of the invention, because the PAC is evenly distributed in the photoresist film, resulting in reduced and uniform acid diffusion (relative to prior art schemes), the LWR is substantially reduced.
General Matters
Embodiments of the invention provide a non-chemically amplified photoresist (i.e., does not include PAG), which results in reduced LWR. In accordance with one embodiment the photoresist includes a DSR and a PAC. For one embodiment of the invention, the even distribution of the PAC within the DSR results in substantially reduced acid diffusion thus reducing LWR. Prior to exposure to the light source, the PAC inhibits solubility of the DSR in the developer. Upon exposure the PAC converts to acid to promote solubility of the DSR in the developer. The uniform distribution of the PAC within the photoresist results in substantially reduced LWR as well as a reduction in defects such as nubs, points, and black dot defects.
For one embodiment the photoresist is applied in the EUV technology (e.g., wavelength is 13.4 nm). For such an embodiment the LWR may be reduced to a desired length of less than 1.5 nm, allowing for effective fabrication of devices having feature sizes of approximately 15 nm.
While the invention has been described in terms of several embodiments, those skilled in the art will recognize that the invention is not limited to the embodiments described, but can be practiced with modification and alteration within the spirit and scope of the appended claims. The description is thus to be regarded as illustrative instead of limiting.